Prospects of antidiabetic drugs in the treatment of neurodegenerative disease

Prospects of antidiabetic drugs in the treatment of neurodegenerative disease

Abstract Neurodegenerative diseases (NDs) stand for a group of disorders characterized by the progressive loss of neurons in the brain and peripheral organs, resulting in motor and cognitive dysfunction. The global prevalence of NDs, including Alzheimer's disease, Parkinson's disease, Hunt...

Full description

Bibliographic Details
Main Authors:	Lidan Hu, Wenmin Wang, Xiangjun Chen, Guannan Bai, Liangjian Ma, Xin Yang, Qiang Shu, Xuekun Li
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	Brain-X
Subjects:	antidiabetic drug insulin resistance neurodegenerative disease neuroprotective type 2 diabetes mellitus
Online Access:	https://doi.org/10.1002/brx2.52

Similar Items

How many oral antidiabetic drugs before insulin?
by: Jayant Kelwade, et al.
Published: (2017-01-01)

Effects of antidiabetic drugs on bone metabolism
by: Padilla Apuntate Nuria, et al.
Published: (2024-04-01)

Vanadium Compounds with Antidiabetic Potential
by: Luísa M. P. F. Amaral, et al.
Published: (2023-10-01)

ANTIDIABETIC EFFECTS OF MEDICINAL PLANTS
by: A. O. Ojetunde
Published: (2021-03-01)

Antidiabetic Drugs in Breast Cancer Patients
by: Wojciech Garczorz, et al.
Published: (2024-01-01)

Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients
by: Nova Hasani Furdiyanti, et al.
Published: (2018-02-01)

COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL
by: TRI MURTI ANDAYANI, et al.
Published: (2007-01-01)

Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review
by: Kamil Wdowiak, et al.
Published: (2022-06-01)

Antidiabetic Properties of Plant Secondary Metabolites
by: Stanislav Sukhikh, et al.
Published: (2023-04-01)

Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development
by: Safaet Alam, et al.
Published: (2022-02-01)

Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
by: Belén Picatoste, et al.
Published: (2023-03-01)

Changes in antidiabetic drug prescription patterns during follow-up of the GERODIAB cohort. Comparison with professional recommendations
by: Jean Doucet, et al.
Published: (2023-01-01)

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)
by: Hiroshi Maegawa, et al.
Published: (2021-03-01)

Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment
by: Kalyan Kumar Gangopadhyay, et al.
Published: (2017-01-01)

Dose modification of antidiabetic agents in patients with type 2 diabetes mellitus and heart failure
by: D C Sharma, et al.
Published: (2017-01-01)

Potential of marine compounds in the treatment of neurodegenerative diseases: a review
by: P. L. Guimarães, et al.
Published: (2023-03-01)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
by: Yue Fei, et al.
Published: (2019-08-01)

Pharmacogenetics of new classes of antidiabetic drugs
by: Selma Imamovic Kadric, et al.
Published: (2021-12-01)

Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving
by: Eduardo Gutiérrez-Abejón, et al.
Published: (2020-07-01)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
by: Caridad Ivette Fernandez, et al.
Published: (2017-12-01)

Guidelines for the antidiabetic assay for bioactive substances in cell model
by: Hui Teng, et al.
Published: (2022-12-01)

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
by: Zahra Azizi, et al.
Published: (2022-07-01)

Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
by: Xue Jiang, et al.
Published: (2022-11-01)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
by: Bao Sun, et al.
Published: (2021-01-01)

Berberine: A Promising Treatment for Neurodegenerative Diseases
by: Ziqian Cheng, et al.
Published: (2022-05-01)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
by: Michalis Michailidis, et al.
Published: (2022-04-01)

Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
by: I.I. Stoyanova
Published: (2014-12-01)

Berberine and Its Study as an Antidiabetic Compound
by: Ayudiah Rizki Utami, et al.
Published: (2023-07-01)

Antidiabetic Regimen and Factors Associated with Glycemic Control in Patients with Type 2 Diabetes mellitus in Public Health Centers in Jakarta: A Cross-Sectional Study
by: Nora Wulandari, et al.
Published: (2021-09-01)

Effects of short-term combination therapy with insulin on glycoregulation and insulin secretory function in patients with type 2 diabetes mellitus and secondary failure to treatment with oral antidiabetic agents
by: Gabrijela Malešević, et al.
Published: (2019-07-01)

The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
by: Fengyuan Lu, et al.
Published: (2023-09-01)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
by: Wenhui Liu, et al.
Published: (2022-05-01)

Antidiabetic Potential of Medicinal Plants and Their Active Components
by: Bahare Salehi, et al.
Published: (2019-09-01)

Pharmacological evaluation of medicinal plants with antidiabetic activities in Ethiopia: A review
by: Zemene Demelash Kifle, et al.
Published: (2022-03-01)

Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs
by: Faiza Lamine, et al.
Published: (2016-02-01)

Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)
by: Noriharu Yagi, et al.
Published: (2022-01-01)

Prevalence of diabetes mellitus and antidiabetic drug utilization in the Eastern Bosnia and Herzegovina: A pilot study
by: Popržen Jelena D., et al.
Published: (2018-01-01)

Genus Boswellia as a new candidate for neurodegenerative disorders
by: Arezoo Rajabian, et al.
Published: (2020-03-01)

Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
by: Olakunle Bamikole Afolabi, et al.
Published: (2023-06-01)

Effects of age and tissue of Juniperus sabina L. on its phytochemical characteristics, anti-cholinesterase, antidiabetes, and anti-drug resistant bacteria activities
by: Shengnan Xu, et al.
Published: (2023-09-01)